Aaron G.l. Fletcher, Director at Cue Biopharma, Inc. (CUE), bought 735,000 shares at $4.76 ($3.5M) on 2022-03-31, disclosed to the SEC on 2022-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TFFP | BUY | 2022-11-23 | $50K | — | Filing → |
| CUE | BUY | 2022-05-25 | $712K | — | Filing → |
| TFFP | BUY | 2022-05-17 | $538K | — | Filing → |